The RAS/RAF-MEK1/2-ERK1/2 signalling cascade is deregulated in approximately 50% of colorectal tumours, which drives tumour progression through constitutive ERK1/2 activity16–18. This evidence concerns the gene MAP2K1 and colorectal neoplasm.